WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sets New 52-Week High – What’s Next?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) reached a new 52-week high on Monday . The stock traded as high as $13.6950 and last traded at $13.4450, with a volume of 1847 shares. The stock had previously closed at $12.79.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, WuXi Biologics (Cayman) currently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Price Performance

The stock has a 50-day simple moving average of $11.44 and a 200-day simple moving average of $9.62.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.